Antares Pharma, Inc. (ATRS)

Net Income

$42.46M

TTM · Period ending: · USD

ATRS logo

ATRS Net Income

Latest reported$42.46M
ATRS TTM Net Income (-$2.24M → $42.46M)
High-resolution chart · PNG

ATRS net income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Net Income — Trailing twelve months (TTM) (USD)
Period endingNet Income (USD)
42,461,000
48,575,000
67,278,000
66,881,000
62,350,000
56,201,000
9,510,000
5,557,000
1,156,000
-2,027,000
-588,000
-3,567,000
-5,861,000
-6,515,000
-16,363,618
-19,880,139
-18,200,083
-16,743,000
-17,528,630
-18,197,092
-21,418,611
-24,338,804
-26,465,041
-26,082,099
-21,527,282
-20,658,846
-24,105,305
-25,553,705
-33,144,784
-35,151,715
-30,713,886
-29,887,402
-25,892,933
-20,506,776
-19,883,406
-17,057,688
-14,761,504
-11,427,450
-6,569,636
-4,334,656
-3,081,681
-4,387,920
-5,532,590
-5,864,731
-5,862,888
-6,091,198
-7,199,197
-8,461,631
-9,162,988
-10,290,752
-10,627,303
-10,922,303
-11,929,462
-12,690,453
-13,188,890
-12,610,788
-11,647,056
-8,578,939
-6,751,071
-6,065,206
-6,224,912
-8,099,845
-8,606,851
-8,658,613
-8,529,598
-8,497,956
-9,121,564
-9,364,120
-8,726,977
-8,348,532
-8,590,162
-29,715,965
-31,694,940
-32,817,964
-33,724,888
-14,232,253
-12,479,576
-11,608,765
-10,925,418
-9,229,955
-8,991,794
-8,461,481
-7,583,024
-6,551,416
-5,789,733
-5,015,878
-4,188,233
-4,162,951
-4,245,911
-3,703,439
-4,969,464
-5,169,464
-5,269,464
-5,769,464
-3,871,767
-3,471,767
-3,171,767
-2,971,767
-2,838,568
-2,538,568
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.